Return of the lysergamides. Part II: Analytical and behavioural characterization of N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ)
- PMID: 27265891
- PMCID: PMC5411264
- DOI: 10.1002/dta.1985
Return of the lysergamides. Part II: Analytical and behavioural characterization of N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ)
Abstract
Lysergic acid N,N-diethylamide (LSD) is perhaps one of the most intriguing psychoactive substances known and numerous analogs have been explored to varying extents in previous decades. In 2013, N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ) appeared on the 'research chemicals'/new psychoactive substances (NPS) market in both powdered and blotter form. This study reports the analytical characterization of powdered AL-LAD and LSZ tartrate samples and their semi-quantitative determination on blotter paper. Included in this study was the use of nuclear magnetic resonance (NMR) spectroscopy, gas chromatography-mass spectrometry (GC-MS), low and high mass accuracy electrospray MS(/MS), high performance liquid chromatography diode array detection and GC solid-state infrared analysis. One feature shared by serotonergic psychedelics, such as LSD, is the ability to mediate behavioural responses via activation of 5-HT2A receptors. Both AL-LAD and LSZ displayed LSD-like responses in male C57BL/6 J mice when employing the head-twitch response (HTR) assay. AL-LAD and LSZ produced nearly identical inverted-U-shaped dose-dependent effects, with the maximal responses occurring at 200 µg/kg. Analysis of the dose responses by nonlinear regression confirmed that LSZ (ED50 = 114.2 nmol/kg) was equipotent to LSD (ED50 = 132.8 nmol/kg) in mice, whereas AL-LAD was slightly less potent (ED50 = 174.9 nmol/kg). The extent to which a comparison in potency can be translated directly to humans requires further investigation. Chemical and pharmacological data obtained from NPS may assist research communities that are interested in various aspects related to substance use and forensic identification. Copyright © 2016 John Wiley & Sons, Ltd.
Keywords: 5-HT2A receptors; LSD; lysergamides; new psychoactive substances; psychedelics.
Copyright © 2016 John Wiley & Sons, Ltd.
Figures
Similar articles
-
Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).Drug Test Anal. 2018 Feb;10(2):310-322. doi: 10.1002/dta.2222. Epub 2017 Jul 27. Drug Test Anal. 2018. PMID: 28585392 Free PMC article.
-
Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).Drug Test Anal. 2016 Sep;8(9):891-902. doi: 10.1002/dta.1884. Epub 2015 Oct 12. Drug Test Anal. 2016. PMID: 26456305 Free PMC article.
-
Return of the lysergamides. Part III: Analytical characterization of N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD).Drug Test Anal. 2017 Oct;9(10):1641-1649. doi: 10.1002/dta.2196. Epub 2017 May 10. Drug Test Anal. 2017. PMID: 28342178 Free PMC article.
-
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.Curr Top Behav Neurosci. 2018;36:45-73. doi: 10.1007/7854_2017_478. Curr Top Behav Neurosci. 2018. PMID: 28677096 Free PMC article. Review.
-
An overview of emerging and new psychoactive substances in the United Kingdom.Forensic Sci Int. 2016 Oct;267:25-34. doi: 10.1016/j.forsciint.2016.08.013. Epub 2016 Aug 11. Forensic Sci Int. 2016. PMID: 27552699 Review.
Cited by
-
Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).Drug Test Anal. 2018 Feb;10(2):310-322. doi: 10.1002/dta.2222. Epub 2017 Jul 27. Drug Test Anal. 2018. PMID: 28585392 Free PMC article.
-
Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ).Drug Test Anal. 2020 Oct;12(10):1514-1521. doi: 10.1002/dta.2911. Epub 2020 Sep 17. Drug Test Anal. 2020. PMID: 32803833 Free PMC article.
-
Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.Drug Test Anal. 2022 Aug;14(8):1503-1518. doi: 10.1002/dta.3281. Epub 2022 May 29. Drug Test Anal. 2022. PMID: 35524430 Free PMC article.
-
Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).Neuropharmacology. 2020 Aug 1;172:107856. doi: 10.1016/j.neuropharm.2019.107856. Epub 2019 Nov 19. Neuropharmacology. 2020. PMID: 31756337 Free PMC article.
-
Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.Handb Exp Pharmacol. 2018;252:227-260. doi: 10.1007/164_2018_107. Handb Exp Pharmacol. 2018. PMID: 29532180 Free PMC article.
References
-
- Stoll A, Hofmann A. Partialsynthese von Alkaloiden vom Typus des Ergobasins. 6. Mitteilung über Mutterkornalkaloide. Helv. Chim. Acta. 1943;26:944.
-
- Stoll WA. Lysergsäure-diäthylamid, ein Phantastikum aus der Mutterkorngruppe. Schweiz. Arch. Neurol. Psychiat. 1947;60:279.
-
- Nichols DE. Hallucinogens. Pharmacol. Ther. 2004;101:131. - PubMed
-
- Hintzen A, Passie T. The Pharmacology of LSD. A Critical Review. Oxford: Oxford University Press / Beckley Foundation Press; 2010.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
